Supporting Information

Pouryahya et al.

SI Text Table S1 presents with the highest absolute value of Ricci curvature. We expect these genes to have significant contribution to the network’s robustness. Notably, the top two genes are TP53 (tumor 53) and YWHAG . TP53, also known as , it is a well known known as the "guardian of the genome“ given the essential role it plays in genetic stability and prevention of cancer formation (1, 2). Mutations in this gene play a role in all stages of malignant transformation including tumor initiation, promotion, aggressiveness, and metastasis (3). Mutations of this gene are present in more than 50% of human cancers, making it the most common genetic event in human cancer (4, 5). Namely, p53 mutations play roles in leukemia, breast cancer, CNS cancers, and lung cancers, among many others (6–9). The YWHAG gene encodes the 14-3-3 protein gamma, a member of the 14-3-3 family which are involved in many biological processes including signal transduction regulation, pro- gression, , cell adhesion and migration (10, 11). Notably, increased expression of 14-3-3 family proteins, including protein gamma, have been observed in a number of human cancers including lung and colorectal cancers, among others, suggesting a potential role as tumor oncogenes (12, 13). Furthermore, there is evidence that loss Fig. S1. The histogram of scalar Ricci curvature of 8240 genes. Most of the genes have negative scalar Ricci curvature (75%). TP53 and YWHAG have notably low of p53 function may result in upregulation of 14-3-3γ in lung cancer Ricci curvatures. (11).

Table S1. Top 40 genes ranked in ascending order of scalar Ricci 6. Zhao Z, et al. (2010) p53 loss promotes by enabling aberrant self- curvature in the pre-treatment network. renewal. Genes Dev 24(13):1389-1402. 7. Gasco M, Shami S, Crook T (2002) The p53 pathway in breast cancer. Breast Cancer Res. Gene ranking Gene name Gene ranking Gene name 4(2). 8. Jin Y, Xiao W, Song T, Feng G, Dai Z (2016) Expression and Prognostic Significance of p53 1 TP53 21 CALM1 in Glioma Patients: A Meta-analysis. Neurochem Res 41(7):1723-1731. 2 YWHAG 22 CASP3 9. Ahrendt SA, et al. (2003) p53 mutations and survival in stage I non-small-cell lung cancer: 3 EP300 23 CCDC85B results of a prospective study. J Natl Cancer Inst. 95(13):961-970. 10. Horie M, Suzuki M, Takahashi E, Tanigami A (1999) Cloning, expression, and chromosomal 4 PRKCA 24 CTNNB11 mapping of the human 14-3-3gamma gene (YWHAG) to 7q11.23. Genomics 60(2):241-243. 5 CREBBP 25 VIM 11. Chen DY, Dai DF, Hua Y, Qi WQ (2015) p53 suppresses 14-3-3γ by stimulating proteasome- 6 CSNK2A1 26 AR mediated 14-3-3γ protein degradation. Int J Oncol 46(2):818-824. 7 UBQLN4 27 CDK1 12. Qi W, Liu X, Qiao D, Martinez JD (2005) Isoform-specific expression of 14-3-3 proteins in human lung cancer tissues. Int J Cancer 113(3):359-363. 8 SRC 28 FYN 13. Radhakrishnan VM, Martinez JD (2015) 14-3-3gamma induces oncogenic transformation by 9 PRKACA 29 RB1 stimulating MAP kinase and PI3K signaling. PLoS One 5(7):e11433. 10 SMAD3 30 SMAD9 11 SMAD2 31 YWHAZ 12 GRB2 32 YWHAB 13 TRAF2 33 ACTB 14 ATXN1 34 UBE2I 15 ESR1 35 HDAC1 16 TGFBR1 36 AKT1 17 EWSR1 37 APP 18 EGFR 38 MDFI 19 SMAD4 39 SMAD1 20 MAPK1 40 ACTA1

1. Lane DP (1992) Cancer. p53, guardian of the genome. Nature 358(6381):15-16. 2. Surget S, Khoury MP,Bourdon JC (2013) Uncovering the role of p53 splice variants in human malignancy: a clinical perspective. Onco Targets Ther 7:57-68. 3. Rivlin N, Brosh R, Oren M, Rotter V (2011) Mutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of Tumorigenesis. Genes Cancer 2(4):466-474. 4. Levine AJ, Oren M (2009) The first 30 years of p53: growing ever more complex. Nat Rev Cancer 9(10):749-758. 5. Freed-Pastor WA, Prives C (2012) Mutant p53: one name, many proteins. Genes Dev 26(12):1268-1286.

Pouryahya et al. 1 of9 Fig. S2. The pre-treatment network visualization (via Gephi). The network consists of 8240 nodes (genes) and 67235 edges. The size of the nodes are proportional to the node-degree and the colors of the nodes correspond to the sign of the scalar Ricci curvature of that node. TP53 has a very high node-degree as well as a distinctively low Ricci curvature.

2 of9 Pouryahya et al. Table S2. Drug ranking of 106 anticancer agents based on the average Ricci curvature of significantly correlated genes.

Drug ranking Drug name Drug ranking Drug name Drug ranking Drug name 1 ’Salinomycin’ 41 ’Acetalax’ 80 ’8-Chloro-adenosine’ 2 ’Gefitinib’ 42 ’Staurosporine’ 81 ’OSI-027’ 3 ’Homoharringtonine’ 43 ’ mesilate’ 82 ’’ 4 ’Mitomycin’ 44 ’Tanespimycin’ 83 ’LMP-400’ 5 ’’ 45 ’Triciribine phosphate’ 84 ’’ 6 ’Geldanamycin Analog’ 46 ’7-Tert-butyldimethylsilyl-10 85 ’’ 7 ’Cabozantinib’ -hydroxycamptothecin’ 86 ’Lapatinib’ 8 ’’ 47 ’Hydroxyurea’ 87 ’Ponatinib’ 9 ’PX-316’ 48 ’Alvespimycin’ 88 ’’ 10 ’Raloxifene’ 49 ’’ 89 ’Dromostanolone Propionate’ 11 ’Pipamperone’ 50 ’Nilotinib’ 90 ’’ 12 ’Erlotinib’ 51 ’Apaziquone’ 91 ’’ 13 ’’ 52 ’’ 92 ’Lificguat’ 14 ’Imatinib’ 53 ’’ 93 ’Navitoclax’ 15 ’’ 54 ’Imexon’ 94 ’6-’ 16 ’’ 55 ’RH1’ 95 ’Uracil mustard’ 17 ’Simvastatin’ 56 ’’ 96 ’6-Thioguanine’ 18 ’Batracylin’ 57 ’Estramustine’ 97 ’’ 19 ’’ 58 ’’ 98 ’Pazopanib’ 20 ’’ 59 ’’ 99 ’Perifosine’ 21 ’Itraconazole’ 60 ’Everolimus’ 100 ’7-Ethyl-10-hydroxycamptothecin’ 22 ’Dasatinib’ 61 ’’ 101 ’Calusterone’ 23 ’’ 62 ’Vemurafenib’ 102 ’Allopurinol’ 24 ’Ibrutinib’ 63 ’’ 103 ’’ 25 ’Tyrothricin’ 64 ’Buthionine sulphoximine’ 104 ’Triapine’ 26 ’Crizotinib’ 65 ’’ 105 ’Fluphenazine’ 27 ’’ 66 ’Dexrazoxane’ 106 ’Alvocidib’ 28 ’Trametinib’ 67 ’Abexinostat’ 29 ’Fenretinide’ 68 ’Rapamycin’ 30 ’Tamoxifen’ 69 ’Hypothemycin’ 31 ’’ 70 ’Okadaic acid’ 32 ’Selumetinib’ 71 ’Acrichine’ 33 ’Actinomycin D’ 72 ’Sunitinib’ 34 ’Denileukin Diftitox’ 73 ’Nandrolone phenpropionate’ 35 ’’ 74 ’’ 36 ’Mithramycin’ 75 ’Midostaurin’ 37 ’Depsipeptide’ 76 ’’ 38 ’’ 77 ’’ 39 ’’ 78 ’’ 40 ’’ 79 ’Carfilzomib’

Pouryahya et al. 3 of9 Fig. S3. Top ten biological processes from the enrichment analysis of the significant genes correlated to the top ranked drugs of colon cancer. Colon cancer has fewer cell lines (7 cell lines) than lung and renal cancer (8 cell lines). The top ranked biological process (negative regulation of cellular process) in colon cancer is also the second ranked biological process in renal cancer and fifth ranked biological process of all cancer types. However, most of the top ranked biological processes of colon cancer are quite general.

Fig. S5. Top ten biological processes from the gene ontology enrichment analysis of the significant genes correlated to the top ranked drugs of renal cancer. Cellular Fig. S4. Top ten biological processes from the gene ontology enrichment analysis of localization is a top ranked biological process for renal cancer as well as all 58 cancer the significant genes correlated to the top ranked drugs of lung cancer. Four of the type cell lines. top ranked biological processes are involved with cellular component organization/ assembly.

4 of9 Pouryahya et al. Table S3. Top 200 genes selected for the gene ontology enrichment analysis. First column corresponds to all 58 cell line analysis. The second, third and forth columns are cancer specific results.

All Cancer Cell Lines Colon Cancer Lung Cancer Renal Cancer 'B4GALT3' 'TNPO3' 'BICD2' 'PRUNE2' 'BMF' 'HIVEP1' 'KIAA0513' 'RTN4IP1' 'FAM178B' 'TGFBR3' 'PEX19' 'RTN4R' 'RASSF8' 'CLCN3' 'SIGIRR' 'SSBP2' 'RNF31' 'CLDN3' 'WWC1' 'SF1' 'TEAD2' 'MET' 'ZFAND6' 'ADAM19' 'CCS' 'CD9' 'NFE2L2' 'CD177' 'COPS6' 'FAF1' 'PTGES3' 'ZNF655' 'DHX15' 'PTGFRN' 'RGS19' 'AASDHPPT' 'PCSK9' 'EXOSC8' 'TFG' 'CENPF' 'USP53' 'ZFP36' 'HIST2H2BE' 'HINFP' 'AGFG2' 'RSRC1' 'MIS12' 'NR2F2' 'ANKHD1' 'GTF2F2' 'NACA' 'NR2F6' 'FOXP4' 'CCS' 'SMNDC1' 'NUP133' 'NCAPG' 'FLNC' 'STX16' 'PLCE1' 'OAZ1' 'SOD1' 'TICAM1' 'TUBGCP4' 'RILP' 'GNMT' 'TOP1' 'ANXA5' 'SAR1A' 'PTBP1' 'GPS2' 'FKBP4' 'ZNF337' 'SIPA1L1' 'ABCB8' 'GLMN' 'NUMBL' 'SPARC' 'FAM57A' 'RRAD' 'BRIP1' 'COMMD1' 'ICAM3' 'SUPT4H1' 'CREM' 'MAPKAPK2' 'SKI' 'SUZ12' 'ADCY6' 'TCHP' 'SLC3A2' 'EIF3C' 'MTSS1' 'TOM1L1' 'TRIM32' 'ATP6V0C' 'CELSR2' 'USP5' 'USP40' 'DCP2' 'GMEB2' 'VLDLR' 'CLINT1' 'DDB1' 'SESN2' 'TUBGCP4' 'GLYCTK' 'DPYSL2' 'SHMT2' 'HES6' 'HDHD3' 'FOXO3' 'VPS41' 'NEU4' 'MITF' 'GMEB2' 'RANGAP1' 'STAM' 'OTX2' 'KIFAP3' 'DEXI' 'CUL2' 'RAB11FIP2' 'KLHL8' 'INVS' 'GLS2' 'SHOC2' 'PPM1B' 'CDYL' 'MFN1' 'STAMBPL1' 'RAPGEF2' 'FBXW8' 'BMP7' 'TLN1' 'SERPINA1' 'MAVS' 'NCBP2' 'ZMYND11' 'SMAD1' 'MIER1' 'RMND5B' 'TIMM22' 'TOX4' 'NRSN2' 'ZP4' 'SCG5' 'UBTF' 'PDE6D' 'RAB14' 'ABCD1' 'USP5' 'PUM1' 'ATP2B1' 'VAMP4' 'DNM1L' 'SLC12A2' 'CASKIN1' 'ADRBK2' 'MAP3K10' 'SOX4' 'FTH1' 'AES' 'ATF7IP2' 'TINF2' 'IREB2' 'BCL7A' 'DARS' 'ZRSR2' 'MT2A' 'KIF11' 'FBXO44' 'SAV1' 'PARVA' 'LYPLA1' 'NEU1' 'EPS15' 'POLDIP2' 'MAPK8IP3' 'NUDT14' 'CCDC88A' 'SEMA4B' 'PVR' 'PIGC' 'CBS' 'SPINK7' 'TOMM20' 'POMP' 'EPS15L1' 'STRADB' 'PKP4' 'POP4' 'NEO1' 'CHFR' 'TNFSF10' 'RSRC1' 'CDK13' 'PPIE' 'HNRNPK' 'RAB9A' 'DOCK7' 'RAB13' 'CSE1L' 'SAP30BP' 'JAKMIP1' 'SNF8' 'CENPF' 'TM9SF2' 'ANKS1A' 'TFAP2A' 'ARPC3' 'BMP6' 'CA9' 'VEGFB' 'DMC1' 'CACHD1' 'SCP2' 'ADRA2C' 'RPL6' 'DMTF1' 'KEAP1' 'CEBPE' 'RPL22' 'DNAJC5' 'SEC61A1' 'PRPS1' 'HSPA9' 'GBP1' 'PLEKHA5' 'DAAM1' 'EPN1' 'NEK2' 'SERP1' 'HERC5' 'GIGYF1' 'SIL1' 'DHX38' 'IDO1' 'PPARA' 'SNUPN' 'GJA5' 'PSMB4' 'STRADB' 'XRCC1' 'GSPT2' 'RBCK1' 'ZRANB1' 'ARL4A' 'SYT4' 'UBE2M' 'LBR' 'C10orf2' 'SYT6' 'UBE2Z' 'POLB' 'SLC25A4' 'SYTL3' 'ZNF764' 'HMOX1' 'MARCKS' 'SS18' 'ATP5C1' 'IRF8' 'FBXO6' 'SPNS1' 'METTL1' 'CEP250' 'RALGPS2' 'AKR1B1' 'CHMP2A' 'DNPEP' 'TXNIP' 'ARL6IP4' 'CYB5A' 'KSR1' 'APPBP2' 'PRCP' 'EIF4G1' 'NME3' 'GUSB' 'RCAN2' 'ISOC2' 'RNF8' 'MFSD3' 'HOXD9' 'POR' 'SRCAP' 'SLC8A1' 'CENPBD1' 'PPM1B' 'TFPI2' 'MXD1' 'DPPA2' 'RHEB' 'HDAC7' 'RND3' 'ACAT2' 'ZNF510' 'RANBP10' 'TERF1' 'SF3B3' 'ADCY5' 'KLHL26' 'DLG5' 'HSD17B14' 'CASP3' 'AKAP10' 'CCNL2' 'DCC' 'IFNAR1' 'GCA' 'USP8' 'MID2' 'BAK1' 'PSMC1' 'A1CF' 'DPPA4' 'ADAM33' 'PSMC2' 'APOBEC1' 'OTX2' 'CLIC1' 'SRI' 'CD22' 'VPS25' 'PPP3CA' 'WDR37' 'CYP11A1' 'HOOK3' 'MEAF6' 'YBX1' 'FBLN1' 'PEX14' 'RELA' 'SMG5' 'IGHM' 'FOXP2' 'NIPSNAP1' 'ENAH' 'LAMA3' 'PIAS2' 'RGS2' 'STAT1' 'STK24' 'PAK3' 'RAB38' 'CHORDC1' 'IK' 'PRDM1' 'RHOG' 'MAPRE3' 'HIVEP1' 'C19orf43' 'SDC2' 'PPP5C' 'AGR2' 'GLRX' 'TRA2B' 'DCTN1' 'CLK2' 'PLEKHA4' 'KHSRP' 'PTPN3' 'ERN1' 'LSR' 'PDCD2' 'SRGAP1' 'MAP3K6' 'CCDC53' 'PFDN4' 'CDC25B' 'NDFIP1' 'SLC16A1' 'ST13' 'CSNK2A1' 'RAPGEF6' 'STIM1' 'DYNLT3' 'HMG20B' 'ULK2' 'ZNF423' 'PIAS4' 'KIF4A' 'CD46' 'KCNK9' 'SUMO3' 'NES' 'ARL15' 'SRPK2' 'OCRL' 'PDCD2' 'DKK1' 'ATP2B2' 'CLU' 'STX6' 'RIPK1' 'ISOC2' 'TSG101' 'SPG21' 'CDC23' 'PPFIA4' 'POLA2' 'C1QBP' 'ATP1B1' 'FOXN3' 'RLF' 'DDB2' 'CPSF3' 'HOXA10' 'TERF2IP' 'EPAS1' 'ITSN1' 'PIK3AP1' 'IL6' 'ACTC1' 'ERBB2IP' 'PLIN2' 'IPO5' 'HSPH1' 'CHEK2' 'RELL1' 'SH3KBP1' 'S100A10' 'ASS1' 'SERPINB1' 'CAMK2D' 'HIP1R' 'BAG1' 'SLC4A2' 'CRIP1' 'RHPN2' 'EIF2S3' 'SOX18' 'IL1A' 'EMB' 'MAP4K2' 'TMCO6' 'KPNA5' 'RABAC1' 'PDIA3' 'ZNF136' 'LATS1' 'USF2' 'PSG9' 'RASSF7' 'SERPINB6' 'VAMP1' 'SEMA4B' 'NOL12' 'TINAG' 'LIG4' 'SH3BP2' 'RWDD3' 'PA2G4' 'NIN' 'TPBG' 'DMPK' 'NLRP12' 'SERTAD2' 'CCNK' 'ABHD5' 'PYCARD' 'TFDP1' 'PHPT1' 'PLIN1' 'SUMO4' 'PSMB6' 'ADAM15' 'HNRNPA2B1' 'DHCR24' 'TRAF7' 'DISC1' 'TXNIP' 'CEACAM5' 'CENPE' 'KCTD5' 'LATS1' 'VPS72' 'RABGGTA' 'ATPAF2' 'SEC23IP' 'TERF1' 'RBM4' 'CITED4' 'AP2A1' 'EIF2B1' 'FAM103A1' 'DEDD' 'STIM2' 'MAP3K11' 'FAT1' 'GABRR2' 'RBM39' 'PNMA1' 'WDR61' 'ING3' 'MESDC1' 'HMGB1' 'TRAF3IP1' 'KIF1B' 'RNF139' 'BCOR' 'DYRK1B' 'KIF23' 'TMEM139' 'HSD17B4' 'HTRA1' 'LRP12' 'KIF2B' 'APTX' 'POR' 'MPP6' 'ERAP1' 'FBXL12' 'CCDC53' 'PGF' 'RAD54B' 'SMARCA4' 'FAM127A' 'PIGK' 'ERCC3' 'RNPS1' 'CASP7' 'PIGT' 'PATZ1' 'SERPINB9' 'AFTPH' 'RND2' 'HSF4' 'RAP2B' 'ARPC4' 'RTN3' 'RORB' 'NOTCH3' 'UBN1' 'SIRPA' 'EIF4EBP1' 'PPP1R8' 'RANBP3' 'STX5' 'KCNQ1' 'MDK' 'PPIB' 'TIMP2' 'CPEB1' 'PRKAB2' 'TES' 'TWIST1' 'ZC3H7B' 'PRKAG2' 'ANXA2' 'VCPIP1' 'GOLGB1' 'CCNO' 'TGS1' 'LAPTM5' 'CRTC2' 'ADAM10' 'DYNC1I2' 'ROCK1' 'CUX1' 'GTF2H5' 'RBM14' 'ZYX' 'TAF8' 'NGEF' 'DNAJB9' 'MAX' 'C11orf49' 'STRBP' 'SMARCC1' 'FAM160A2' 'FAP' 'GNAZ' 'MED31' 'HOXB8' 'SDSL' 'KAT2B' 'ABCD3' 'RARG' 'SCN8A' 'SH3GL2' 'COL6A2' 'VPS4A' 'PRDM2' 'NBN' 'AIP' 'RPS6' 'AES' 'PDK2' 'TRIP13' 'C14orf166' 'POFUT1' 'APP' 'PIM1' 'NIN' 'ERH' 'APOBEC1' 'CSF2' 'TRIM37' 'TWF1' 'IDH1' 'NAPA' 'AP2A2' 'RB1' 'RAB2A' 'FAM101B' 'BMP5' 'AFG3L2' 'SENP6' 'GABPB1' 'COL7A1' 'TP73' 'PPARA' 'TNFRSF10B' 'DAG1' 'CD3EAP' 'VAMP1' 'DST' 'FZD5' 'STK39' 'HIC2' 'FTL' 'HMG20B' 'SERGEF' 'SLC1A1' 'MUC4' 'PCMT1' 'NUP133' 'GADD45B' 'PRKCE' 'PDGFA' 'APPL2' 'ZBTB43' 'UROS' 'PPP2R5D' 'DHPS' 'XRCC4' 'RIT1' 'SRGN' 'ATF5' 'CTTN' 'CPSF3L' 'STAT6' 'POLE' 'APBA2' 'RAB5A' 'VCL' 'GRIK2' 'NMT2' 'SH3BP4' 'LRP5' 'ARL6IP6' 'SIRT1' 'SMARCD1' 'NUCB1' 'LHX2' 'ABI2' 'KITLG' 'PAK2' 'NPHP3' 'BACE1' 'KIAA1549' 'RASAL2' 'AKIRIN2' 'IGF2BP2' 'KRT81' 'ZMIZ1' 'CLK3' 'MAP2K4' 'PLEKHM1' 'NAT9' 'DYNC1I2' 'BAZ1B' 'HRK' 'WDR77' 'IFIT1' 'MYO1C' 'KRT15' 'ATG12' 'KLF10' 'HOOK1' 'RAB1A' 'EHD1' 'NIPSNAP1' 'VPS41' 'TRIAP1' 'SAE1' 'PLEKHG2' 'MAFG' 'PTPN6' 'HADHB' 'PTPN12' 'CYFIP2' 'ARHGEF12' 'ZMIZ2' 'RABGAP1' 'CBS' 'CNTNAP4' 'UBE2E3' 'RTN4R' 'GRIPAP1' 'DAB2IP' 'AP4E1' 'SEC24C' 'KCNH2' 'FGFR2' 'EGLN3' 'UFD1L' 'MID1' 'LIME1' 'EIF3J' 'ZBTB6' 'MID1IP1' 'MAD2L2' 'ACVR1B' 'HSP90B1' 'UBE2D3' 'MED4' 'STAG2' 'OPHN1' 'MED17' 'NINL' 'CDK5RAP2' 'ARCN1' 'ITSN1' 'POLR1A' 'GADD45A' 'POLA2' 'TPM1' 'POLR1E' 'OLFM2' 'LATS2' 'TRAF3IP2' 'REV3L' 'RPE' 'EXOC8' 'ARID2' 'SIX1' 'TBC1D4' 'STK25' 'PSMC4' 'TBCD' 'TSN' 'EXO1' 'PRPF4' 'VPS36' 'STAG1' 'SORBS2' 'RAP1B' 'MAST2' 'PCBD1' 'PEX6' 'MINK1' 'ORAI2' 'AP2A1' 'KIAA2026' 'RNMT' 'SPRY2' 'PPARD' 'LDHB' 'SMARCE1' 'LGALS13' 'CIR1' 'ARL6' 'PCBP1' 'EWSR1' 'HMG20A' 'LSM11' 'TP53BP2' 'SERPINA1' 'GSTP1' 'ZNF473' 'KPNA2' 'MED6' 'ATP5B' 'SNW1' 'SMURF2' 'CHD9' 'C1QTNF1' 'CTSF' 'UROS' 'GNA11' 'CDCP1' 'PHKB' 'AFF4' 'NRIP1' 'NDUFS7' 'PRKACB' 'ANKRD11' 'RAN' 'PCDH1' 'SLC4A1' 'HDHD3' 'EIF3E' 'ROCK2' 'VDAC3' 'PLAC8' 'SDC1' 'SNPH'